Neurodevelopmental Disorder
14
5
5
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
1 terminated out of 14 trials
85.7%
-0.8% vs benchmark
14%
2 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
Efficacy of LEGO Therapy for Adolescent With Level 1 Autism
Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects
Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal
CongenItal Naevus Cohort for Longitudinal Evaluation
Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome
Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants
Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery in Infants
Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
Biomarkers, Neurodevelopment and Preterm Infants
Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders
NeuroModulation Technique Treatment of Autism
Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants
High Energy Formula Feeding in Infants With Congenital Heart Disease